446263-95-2 Usage
Uses
Used in Pharmaceutical Industry:
6-amino-3-Pyridinepropanoic acid methyl ester is used as a precursor in the production of various medications, particularly those used in the treatment of central nervous system disorders. Its role in the synthesis of these drugs is crucial due to its ability to be incorporated into complex molecular structures that can modulate neurological functions.
Used in Agrochemical Industry:
In the agrochemical sector, 6-amino-3-Pyridinepropanoic acid methyl ester is utilized in the synthesis of certain pesticides and insecticides. Its chemical properties allow it to be a key component in the development of effective and targeted pest control agents.
Used in Organic Synthesis:
6-amino-3-Pyridinepropanoic acid methyl ester has potential applications in organic synthesis due to its reactivity and structural features. It can be used to create a variety of organic compounds for different purposes, including the development of new materials and the improvement of existing ones.
Used in Medicinal Chemistry:
6-amino-3-Pyridinepropanoic acid methyl ester also plays a significant role in medicinal chemistry, where it is involved in the design and synthesis of new pharmaceutical agents. Its unique properties allow researchers to explore novel therapeutic approaches and develop innovative treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 446263-95-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,6,2,6 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 446263-95:
(8*4)+(7*4)+(6*6)+(5*2)+(4*6)+(3*3)+(2*9)+(1*5)=162
162 % 10 = 2
So 446263-95-2 is a valid CAS Registry Number.
446263-95-2Relevant academic research and scientific papers
Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI)
Miller, William H.,Seefeld, Mark A.,Newlander, Kenneth A.,Uzinskas, Irene N.,Burgess, Walter J.,Heerding, Dirk A.,Yuan, Catherine C. K.,Head, Martha S.,Payne, David J.,Rittenhouse, Stephen F.,Moore, Terrance D.,Pearson, Stewart C.,Berry, Valerie,DeWolf Jr., Walter E.,Keller, Paul M.,Polizzi, Brian J.,Qiu, Xiayang,Janson, Cheryl A.,Huffman, William F.
, p. 3246 - 3256 (2007/10/03)
Bacterial enoyl-ACP reductase (FabI) catalyzes the final step in each cycle of bacterial fatty acid biosynthesis and is an attractive target for the development of new antibacterial agents. Our efforts to identify potent, selective FabI inhibitors began w
